A detailed history of Capital Planning Advisors, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Capital Planning Advisors, LLC holds 2,393 shares of ABBV stock, worth $405,924. This represents 0.07% of its overall portfolio holdings.

Number of Shares
2,393
Previous 1,883 27.08%
Holding current value
$405,924
Previous $322,000 46.58%
% of portfolio
0.07%
Previous 0.06%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$163.84 - $199.33 $83,558 - $101,658
510 Added 27.08%
2,393 $472,000
Q2 2024

Aug 12, 2024

SELL
$154.79 - $180.76 $13,002 - $15,183
-84 Reduced 4.27%
1,883 $322,000
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $25,251 - $28,771
-158 Reduced 7.44%
1,967 $358,000
Q4 2023

Feb 12, 2024

SELL
$137.6 - $154.97 $2,339 - $2,634
-17 Reduced 0.79%
2,125 $329,000
Q3 2023

Oct 30, 2023

BUY
$133.59 - $154.65 $39,809 - $46,085
298 Added 16.16%
2,142 $319,000
Q2 2023

Aug 01, 2023

SELL
$132.51 - $164.9 $15,106 - $18,798
-114 Reduced 5.82%
1,844 $248,000
Q1 2023

May 15, 2023

BUY
$144.61 - $166.54 $20,823 - $23,981
144 Added 7.94%
1,958 $312,000
Q4 2022

Feb 09, 2023

BUY
$138.31 - $165.87 $24,619 - $29,524
178 Added 10.88%
1,814 $293,000
Q3 2022

Nov 14, 2022

SELL
$134.21 - $153.93 $9,260 - $10,621
-69 Reduced 4.05%
1,636 $220,000
Q2 2022

Aug 10, 2022

SELL
$137.62 - $174.96 $28,349 - $36,041
-206 Reduced 10.78%
1,705 $261,000
Q1 2022

May 10, 2022

BUY
$131.98 - $163.75 $50,020 - $62,061
379 Added 24.74%
1,911 $310,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $164,582 - $208,244
1,532 New
1,532 $207,000
Q3 2019

Nov 05, 2019

SELL
$62.98 - $75.72 $174,769 - $210,123
-2,775 Closed
0 $0
Q2 2019

Aug 09, 2019

SELL
$65.7 - $83.98 $12,942 - $16,544
-197 Reduced 6.63%
2,775 $202,000
Q1 2019

May 14, 2019

SELL
$77.14 - $90.79 $16,816 - $19,792
-218 Reduced 6.83%
2,972 $240,000
Q4 2018

Feb 13, 2019

SELL
$77.85 - $96.01 $49,045 - $60,486
-630 Reduced 16.49%
3,190 $294,000
Q3 2018

Nov 14, 2018

BUY
$88.91 - $98.84 $44,721 - $49,716
503 Added 15.16%
3,820 $361,000
Q2 2018

Aug 08, 2018

SELL
$89.78 - $106.23 $187,281 - $221,595
-2,086 Reduced 38.61%
3,317 $307,000
Q1 2018

May 15, 2018

BUY
$92.01 - $123.21 $1,840 - $2,464
20 Added 0.37%
5,403 $511,000
Q4 2017

Feb 08, 2018

SELL
$89.56 - $98.21 $2,686 - $2,946
-30 Reduced 0.55%
5,383 $521,000
Q3 2017

Nov 09, 2017

BUY
$69.85 - $89.22 $378,098 - $482,947
5,413
5,413 $481,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $300B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Capital Planning Advisors, LLC Portfolio

Follow Capital Planning Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Planning Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Planning Advisors, LLC with notifications on news.